Koca, SSPehlivan, YAkar, SSenel, SKaradeniz, HSosyal, OYazici, AYilmaz, SSagir, RPInanc, NKaratas, ACetin, GYOnen, F2025-04-102025-04-100003-4967http://hdl.handle.net/20.500.14701/42900EnglishDISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITISMeeting Abstract1468-2060